Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
brief summary
This study is a prospective, multinational, observational investigation designed to elucidate the real-world effectiveness and treatment patterns of dupilumab therapy in adult patients diagnosed with prurigo nodularis (PN). The primary objective of this study is to comprehensively characterize the real-world usage of dupilumab for the management of PN. In addition to this, the study aims to achieve several secondary objectives, including a detailed assessment of the medical history, socio-demographic and disease characteristics of dupilumab-treated PN patients, as well as the evaluation of the long-term real-world effectiveness of dupilumab therapy for PN.
detailed description
The follow-up period will be 18 months or until death, loss to follow-up, or withdrawal, whichever comes first.
official title
A Prospective Observational Study of Patients Receiving Dupilumab for Prurigo Nodularis